Ingenome Inc - San Diego, California 92130

Ingenome Inc is categorized under in San Diego, CA .

Business Name: Ingenome Inc
Contact Person: M Raafat El-Gewely
Address: 12235 El Camino Real # 200, San Diego, California 92130
Phone Number: (858) 350-2300
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category:
SIC Code: 2834
NAICS Code: 325412
Share This Business:
Related Businesses: Sunovion Pharmaceuticals Inc - San Diego, CA 92130
Ocera Therapeutics Inc - San Diego, CA 92130
Zogenix Inc - San Diego, CA 92130
Centagen - San Diego, CA 92130
Soledad Pharmaceuticals - San Diego, CA 92130
Surefire Diagnostics - San Diego, CA 92130
Mei Pharma Inc - San Diego, CA 92130
Sunovion Respiratory Development Inc - San Diego, CA 92130
Stratum Medical Corp - San Diego, CA 92130
Kuki Atsuo - San Diego, CA 92130
Elcelyx Therapeutics Inc - San Diego, CA 92130
Calixa Therapeutics Inc - San Diego, CA 92130
Ader Enterprises Inc - San Diego, CA 92130
Remora Pharmaceuticals Inc - San Diego, CA 92130
Adamis Pharmaceuticals Corp - San Diego, CA 92130
Brighton Pharmaceuticals Inc - San Diego, CA 92130
Sequel Pharmaceuticals Inc - San Diego, CA 92130
Oprx Pharmaceuticals Inc - San Diego, CA 92130
Sequel Pharmaceuticals - San Diego, CA 92130
Nerveda Inc - San Diego, CA 92130

The company Ingenome Inc provides BOTH services in the form of from its single location in California. 1 to 4 employees work for Ingenome Inc, and the business now earns $100.000 to $499.999 per annum.

Ingenome Inc was launched in 2009 and is classified under SIC code and category 2834 , and NAICS number and grouping 325412 . To contact Ingenome Inc, please call M Raafat El-Gewely with the phone number (858) 350-2300 or visit its single location at 12235 El Camino Real # 200 in San Diego, California 92130.

The location of the single location can also be found using the coordinates 32.940113,-117.239908. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.